LOGIN
ID
PW
MemberShip
2025-05-01 09:50
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Roche 2018 Annualreport
Roche 2018 Annualreport
2019-12-23
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2019-12-23
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
2019-11-15
Risk-Sharing Agreements in the EU: A Systematic Review
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends
2019-11-15
Managed Entry Agreements for
Managed Entry Agreements for Oncology Drugs
2019-11-15
OPINION
[Reporter¡¯s View] Consideration in legislating telemedicine
Reporter's view |
Lee, Jeong-Hwan
[Reporter's View] Prescribing pre-reviewed new drugs
Reporter's view |
Eo, Yun-Ho
[Reporter's View] Enhanced GMP reg for sterile drug products
Reporter's view |
Lee, Hye-Kyung
INTERVIEW
"High hopes for reimbursed Ilaris¡¦a new treatment option"
Dr. Soyoung Lee, Professor of Pediatric & Adolescent Medicine at Hallym University Sacred Heart Hospital
Approval called for drug switching in atopic dermatitis
Dr. Yang Won Lee, Professor in the Department of Dermatology at Konkuk University Medical Center
"Reimb granted to drug switching between JAK inhibitors"
Dr. Seung-Jae Hong, Professor in the Department of Rheumatology at Kyung Hee University Medical Center
¡®New start at a law firm¡¦will become a trusted expert¡¯
Sol Kim, Jung-Eun Kim, Expert Advisors at Shin&Kim Healthcare Team
¡®3 IBD treatment trends¡¦early treatment is the first¡¯
For inflammatory bowel disease
Data
Roche 2018 Annualreport
Roche 2018 Annualreport
NOVARTIS 2018 Annualreport
NOVARTIS 2018 Annualreport
2018 Multinational Pharma Sales
2018 Multinational Pharma Sales
MOST READ
1
Will Enhertu be reimb for HER2-low cancer in Korea?
2
[Reporter's View] Enhanced GMP reg for sterile drug products
3
Hemophilia A drug 'Obizur' available at major hospitals
4
'Early diagnosis¡¤3 combo therapy¡¤tolerance' for COPD Tx
5
13 items including Jakavi receive price cuts in May
6
Ofev will be reimbursed next month
7
'Social discussions needed for indication-based pricing'
8
Launch of a nasal spray vaccine imminent
9
Shingrix sales KRW 42B¡¦ leads shingles vaccine mkt
10
¡®Multiple-indication drugs improve survival rates¡¯